☆ 4.8 Article

A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D

NEW ENGLAND JOURNAL OF MEDICINE (2023)

Related references

Note: Only part of the references are listed.

Article Infectious Diseases

Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202) : a multicentre, randomised, parallel-group, open-label, phase 2 trial

Heiner Wedemeyer et al.

Summary: In this study, the antiviral activity of bulevirtide was investigated in patients with chronic HBV and HDV infection. The results showed that 54% of patients achieved undetectable HDV RNA or a decline of 2 log10 IU/mL or more in HDV RNA after 24 weeks of bulevirtide treatment. However, after cessation of bulevirtide, HDV RNA concentrations rebounded. The study suggests that longer treatment durations and combination therapies should be further investigated.

LANCET INFECTIOUS DISEASES (2023)

Add to Collection

Review Gastroenterology & Hepatology

Interferon-based treatment of chronic hepatitis D

Lisa Sandmann et al.

Summary: Interferon-alfa has been the main treatment for hepatitis D virus (HDV) infection, but only a portion of patients benefit from it. Successful interferon treatment is associated with improved long-term clinical outcomes. Although alternative treatments are being developed, pegylated interferon-alfa still plays an important role. There is a need for better biomarkers to select patients who are likely to benefit from interferon-based treatments.

LIVER INTERNATIONAL (2023)

Add to Collection

Article Gastroenterology & Hepatology

Inhibition of Viral Replication Reduces Transcriptionally Active Distinct Hepatitis B Virus Integrations With Implications on Host Gene Dysregulation

Yao-Chun Hsu et al.

Summary: This study aimed to assess the effect of viral inhibition on hepatocellular carcinogenesis of hepatitis B virus (HBV) infection and explore the correlation between viral integrations and host gene dysregulation. The results showed that viral inhibition can reduce the number of transcriptionally active viral integrations and viral integrations are significantly correlated with host gene dysregulation.

GASTROENTEROLOGY (2022)

Add to Collection

Article Gastroenterology & Hepatology

Hepatitis D virus-induced interferon response and administered interferons control cell division-mediated virus spread

Zhenfeng Zhang et al.

Summary: This study reveals that interferons can efficiently suppress the spread of hepatitis D virus (HDV) through cell division. The HDV-induced interferon response and exogenous interferon treatment both inhibit cell division-mediated HDV spread and accelerate HDV RNA decay.

JOURNAL OF HEPATOLOGY (2022)

Add to Collection

Review Gastroenterology & Hepatology

The changing context of hepatitis D

Mario Rizzetto et al.

Summary: The global epidemiology of hepatitis D is changing with the widespread implementation of hepatitis B vaccination. In high-income countries, the epidemiology of chronic hepatitis D is dual, with distinct characteristics observed in endemic countries. Despite recent progress, therapeutic management of HDV remains unsatisfactory.

JOURNAL OF HEPATOLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

Assembly and infection efficacy of hepatitis B virus surface protein exchanges in 8 hepatitis D virus genotype isolates

Wenshi Wang et al.

Summary: Research has shown that HDVs from different genotypes replicate with varying efficacies. Variations in HDV genomes and HBV envelope proteins are major determinants of HDV egress and entry efficacy.

JOURNAL OF HEPATOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Distinct Bile Acid Profiles in Patients With Chronic Hepatitis B Virus Infection Reveal Metabolic Interplay Between Host, Virus and Gut Microbiome

Zeyu Sun et al.

Summary: Hepatitis B virus can influence the host bile acids metabolic pathway during infection, leading to higher levels of conjugated and primary bile acids in patients with chronic infection. The study also revealed differences in hepatic gene expression and gut microbiome diversity between patients with chronic hepatitis B and healthy controls. This new insight may contribute to the development of novel clinical strategies for managing chronic HBV infection.

FRONTIERS IN MEDICINE (2021)

Add to Collection

Article Gastroenterology & Hepatology

New Treatments for Chronic Hepatitis B Virus/Hepatitis D Virus Infection

Lisa Sandmann et al.

CLINICS IN LIVER DISEASE (2021)

Add to Collection

Review Gastroenterology & Hepatology

Chronic hepatitis D and hepatocellular carcinoma: A systematic review and meta-analysis of observational studies

Dulce Alfaiate et al.

JOURNAL OF HEPATOLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

Long-Term Study of Hepatitis Delta Virus Infection at Secondary Care Centers: The Impact of Viremia on Liver-Related Outcomes

Habiba Kamal et al.

HEPATOLOGY (2020)

Add to Collection

Review Gastroenterology & Hepatology

The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis

Alexander J. Stockdale et al.

JOURNAL OF HEPATOLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

Ten-year follow-up of a randomized controlled clinical trial in chronic hepatitis delta

Anika Wranke et al.

JOURNAL OF VIRAL HEPATITIS (2020)

Add to Collection

Article Infectious Diseases

Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial

Heiner Wedemeyer et al.

LANCET INFECTIOUS DISEASES (2019)

Add to Collection

Article Gastroenterology & Hepatology

Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacy

Cihan Yurdaydin et al.

JOURNAL OF HEPATOLOGY (2019)

Add to Collection

Article Pharmacology & Pharmacy

The NTCP-inhibitor Myrcludex B: Effects on Bile Acid Disposition and Tenofovir Pharmacokinetics

A. Blank et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)

Add to Collection

Article Gastroenterology & Hepatology

Binge drinking and the risk of liver events: A population-based cohort study

Fredrik Aberg et al.

LIVER INTERNATIONAL (2017)

Add to Collection

Article Gastroenterology & Hepatology

AASLD guidelines for treatment of chronic hepatitis B

Norah A. Terrault et al.

HEPATOLOGY (2016)

Add to Collection

Article Gastroenterology & Hepatology

First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B

Antje Blank et al.

JOURNAL OF HEPATOLOGY (2016)

Add to Collection

Article Gastroenterology & Hepatology

Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study

Pavel Bogomolov et al.

JOURNAL OF HEPATOLOGY (2016)

Add to Collection

Article Gastroenterology & Hepatology

Sodium Taurocholate Cotransporting Polypeptide (SLC10A1) Deficiency: Conjugated Hypercholanemia Without a Clear Clinical Phenotype

Frederic M. Vaz et al.

HEPATOLOGY (2015)

Add to Collection

Review Gastroenterology & Hepatology

Genotypes and viral variants in chronic hepatitis B: A review of epidemiology and clinical relevance

Catherine M. N. Croagh et al.

WORLD JOURNAL OF HEPATOLOGY (2015)

Add to Collection

Article Gastroenterology & Hepatology

Hepatitis B and D Viruses Exploit Sodium Taurocholate Co-transporting Polypeptide for Species-Specific Entry into Hepatocytes

Yi Ni et al.

GASTROENTEROLOGY (2014)

Add to Collection

Article Gastroenterology & Hepatology

Late HDV RNA Relapse After Peginterferon Alpha-Based Therapy of Chronic Hepatitis Delta

Benjamin Heidrich et al.

HEPATOLOGY (2014)

Add to Collection

Article Gastroenterology & Hepatology

Binding of Hepatitis B Virus to Its Cellular Receptor Alters the Expression Profile of Genes of Bile Acid Metabolism

Nicola Oehler et al.

HEPATOLOGY (2014)

Add to Collection

Article Gastroenterology & Hepatology

Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation

Marc Luetgehetmann et al.

HEPATOLOGY (2012)

Add to Collection

Article Biology

Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus

Huan Yan et al.

ELIFE (2012)

Add to Collection

Article Medicine, General & Internal

Hepatitis delta virus

Sarah A. Hughes et al.

LANCET (2011)

Add to Collection

Article Medicine, General & Internal

Peginterferon plus Adefovir versus Either Drug Alone for Hepatitis Delta

Heiner Wedemeyer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Add to Collection

Review Infectious Diseases

The natural history of chronic HBV infection and geographical differences

Yun-Fan Liaw et al.

ANTIVIRAL THERAPY (2010)

Add to Collection

Review Gastroenterology & Hepatology

Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead

Heiner Wedemeyer et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)

Add to Collection

Article Gastroenterology & Hepatology

A 28-Year Study of the Course of Hepatitis Δ Infection: A Risk Factor for Cirrhosis and Hepatocellular Carcinoma

Raffaella Romeo et al.

GASTROENTEROLOGY (2009)

Add to Collection

Article Biotechnology & Applied Microbiology

Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein

Joerg Petersen et al.

NATURE BIOTECHNOLOGY (2008)

Add to Collection

Article Gastroenterology & Hepatology

Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B

G Fattovich et al.

GUT (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.